These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9046903)

  • 1. A case of Prader-Willi syndrome with long-term mazindol treatment.
    Inui A; Uemoto M; Takamiya S; Shibuya Y; Baba S; Kasuga M
    Arch Intern Med; 1997 Feb; 157(4):464. PubMed ID: 9046903
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of mazindol in two patients with Prader-Willi syndrome.
    Itoh M; Koeda T; Ohno K; Takeshita K
    Pediatr Neurol; 1995 Nov; 13(4):349-51. PubMed ID: 8771175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term treatment of patients with obesity using mazindol and a reducing diet].
    van Seters AP; Bouwhuis-Hoogerwerf ML; Goslings BM; van Nieuwkoop L; van Slooten H; Struijk-Wielinga T
    Ned Tijdschr Geneeskd; 1982 May; 126(22):990-4. PubMed ID: 7110390
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical studies with mazindol.
    Inoue S
    Obes Res; 1995 Nov; 3 Suppl 4():549S-552S. PubMed ID: 8697057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating diabetes mellitus in Prader-Willi syndrome with Exenatide.
    Seetho IW; Jones G; Thomson GA; Fernando DJ
    Diabetes Res Clin Pract; 2011 Apr; 92(1):e1-2. PubMed ID: 21227526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mazindol, an anorectic of a new series, in the treatment of obesity (author's transl)].
    Dolecek R
    Cas Lek Cesk; 1975 Feb; 114(8):249-54. PubMed ID: 1095197
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mazindol].
    Mori Y
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():683-6. PubMed ID: 21766681
    [No Abstract]   [Full Text] [Related]  

  • 8. Mazindol (Teronac)- another anorectic drug.
    Drug Ther Bull; 1974 Dec; 12(26):101-2. PubMed ID: 4459058
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of obesity in Prader-Willi syndrome.
    Butler MG
    Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):592-3. PubMed ID: 17082801
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of obesity using appetite depressants].
    Ikeda Y
    Nihon Naika Gakkai Zasshi; 1995 Aug; 84(8):1290-4. PubMed ID: 7594950
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug treatment of obesity].
    Meinders AE; Toornvliet AC; Pijl H
    Ned Tijdschr Geneeskd; 1996 Aug; 140(32):1632-4. PubMed ID: 8815403
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of Prader-Willi syndrome accompanied with a renal stone].
    Asanuma H; Nagatsuma K; Baba S; Murai M
    Hinyokika Kiyo; 1998 Jan; 44(1):37-9. PubMed ID: 9503207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlipidemia, insulin-dependent diabetes mellitus, and rapidly progressive diabetic retinopathy and nephropathy in Prader-Willi syndrome with del(15)(q11.2q13).
    Bassali R; Hoffman WH; Chen H; Tuck-Muller CM
    Am J Med Genet; 1997 Aug; 71(3):267-70. PubMed ID: 9268093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anorexiant drugs in the ambulant treatment of obese patients (author's transl)].
    Jenny S; Zimmermann KG; Radielovic P; Bühlmann AA
    Schweiz Rundsch Med Prax; 1976 Jul; 65(28):874-8. PubMed ID: 1005298
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mazindol in the treatment of obese diabetic patients].
    Dolecek R; Reil P; Skarpová O; Závada M
    Vnitr Lek; 1976 Aug; 22(8):798-804. PubMed ID: 788327
    [No Abstract]   [Full Text] [Related]  

  • 16. Delayed onset of pulmonary hypertension associated with an appetite suppressant, mazindol: a case report.
    Hagiwara M; Tsuchida A; Hyakkoku M; Nishizato K; Asai T; Nozawa Y; Tsuchihashi K; Shimamoto K
    Jpn Circ J; 2000 Mar; 64(3):218-21. PubMed ID: 10732856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appetite depressants: weights and measures.
    Hopkins SJ
    Nurs Mirror; 1981 Sep; 153(11):34-5. PubMed ID: 6912546
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of an anorectic agent (Mazindol) on control of obese diabetics.
    Sanders M; Breidahl H
    Med J Aust; 1976 Oct; 2(15):576-7. PubMed ID: 994969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Klinefelter's syndrome and Prader-Willi syndrome: a rare combination.
    Verhoeven WM; de Vries BB; Duffels SJ; Egger JI; Noordam C; Tuinier S
    Psychopathology; 2007; 40(5):356-60. PubMed ID: 17657135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The probable anorexigenic effect of naloxone in the Prader-Labhart-Willi syndrome].
    Mascherpa G; Cogliati F; Mauri R; Resentini M
    Minerva Pediatr; 1982 Aug 15-31; 34(15-16):675. PubMed ID: 7121431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.